Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings per share (EPS) is N/A as of the fiscal period ended Tuesday, September 30, 2025.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-03-31): -0.34.
EARNINGS PER SHARE (EPS)
N/A
EARNINGS PER SHARE (EPS) AVG TTM
-5.70
EARNINGS PER SHARE (EPS) AVG 3Y
-9.83
EARNINGS PER SHARE (EPS) AVG 5Y
-0.70
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
BGM Group Ltd.
Market Cap
$111.14M
Earnings Per Share (EPS)
N/A
TTM Avg
-5.70
3Y Avg
-9.83
5Y Avg
-0.70
Market Cap
$111.39M
Earnings Per Share (EPS)
-3.21
TTM Avg
-1.79
3Y Avg
-1.14
5Y Avg
-1.14
Market Cap
$110.43M
Earnings Per Share (EPS)
-4.80
TTM Avg
-8.13
3Y Avg
-18.81
5Y Avg
-23.77
Market Cap
$110.02M
Earnings Per Share (EPS)
-0.74
TTM Avg
-0.44
3Y Avg
-1.32
5Y Avg
-1.80
Market Cap
$109.80M
Earnings Per Share (EPS)
-1.87
TTM Avg
-4.43
3Y Avg
-5.52
5Y Avg
-12.34
Market Cap
$108.57M
Earnings Per Share (EPS)
-6.48
TTM Avg
-4.79
3Y Avg
-7.51
5Y Avg
-13.98
Market Cap
$108.32M
Earnings Per Share (EPS)
-0.21
TTM Avg
-0.47
3Y Avg
-0.54
5Y Avg
-0.49
Market Cap
$114.08M
Earnings Per Share (EPS)
-0.33
TTM Avg
-0.41
3Y Avg
-0.34
5Y Avg
-0.29
Market Cap
$107.80M
Earnings Per Share (EPS)
-0.71
TTM Avg
-0.33
3Y Avg
-0.37
5Y Avg
-0.32
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BGM Group Ltd. (BGM) | $111.14M | N/A | -5.70 | -9.83 | -0.70 |
| Aardvark Therapeutics, Inc. Common Stock (AARD)vs › | $111.39M | -3.21 | -1.79 | -1.14 | -1.14 |
| Immunic, Inc. (IMUX)vs › | $110.43M | -4.80 | -8.13 | -18.81 | -23.77 |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $110.02M | -0.74 | -0.44 | -1.32 | -1.80 |
| Outlook Therapeutics, Inc. (OTLK)vs › | $109.80M | -1.87 | -4.43 | -5.52 | -12.34 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs › | $108.57M | -6.48 | -4.79 | -7.51 | -13.98 |
| Apyx Medical Corporation (APYX)vs › | $108.32M | -0.21 | -0.47 | -0.54 | -0.49 |
| MaxCyte, Inc. (MXCT)vs › | $114.08M | -0.33 | -0.41 | -0.34 | -0.29 |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $107.80M | -0.71 | -0.33 | -0.37 | -0.32 |
| Genelux Corporation (GNLX)vs › | $116.36M | -0.89 | -0.91 | -0.79 | -0.74 |
Trailing EPS (TTM)
N/A
Forward EPS (Est.)
N/A
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-09-30 | -5.40 |
| 2024-09-30 | -6.00 |
| 2023-09-30 | -32.40 |
| 2022-09-30 | 4.50 |
| 2021-09-30 | 13.50 |
| 2020-09-30 | 21.60 |
| 2019-09-30 | 22.80 |
| 2018-09-30 | 22.20 |
| 2017-09-30 | 6.00 |
